The Genotype Network expands with Japan!

Takuya Mima From Tokyo International Law Office (TKI)

We are pleased to announce that Takuya Mima from Tokyo International Law Office (TKI) has joined as the newest member of The Genotype Network in Japan 🇯🇵

As the world's third-largest pharmaceutical market and a global leader in medical device innovation and regulatory science, Japan plays a crucial role in the international Life Sciences industry, making it an essential hub for companies seeking to advance healthcare solutions worldwide.

Takuya is a Counsel in the Life Sciences Regulatory practice based in Tokyo. TKI is a fast-growing Tokyo-based boutique law firm known for its proactive, business-focused approach, supporting life science and healthcare clients with strategic guidance across complex regulatory and commercial matters. His expertise will significantly enhance our presence in this vital market. His work includes:

• Regulatory & compliance related to pharmaceuticals, medical devices (including SaMD), IVDs, cosmetics, and foodstuffs

•   Research & development-related legal issues including Japan-specific fair competition rules and transparency disclosure obligations applicable to collaborations with HCPs

• IP and commercial agreements, including patent & know-how licensing, R&D agreements, and collaboration agreements

• Litigation before Japanese civil courts

• Strategic legal advice including due diligence in transactions regarding regulatory life sciences aspects

• Technology transfer, corporate restructuring, IP due diligence, and comprehensive due diligence"

  
  

Welcome to The Genotype Network, Takuya!

Lastly, arigatou gozaimasu to Fleur Tuinzing who connected us when she visited Tokyo!